Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E L Morgan

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Federation Proceedings|December 1, 1982
Modulation of the immune response by anaphylatoxin in the microenvironment of the interacting cellsW O Weigle, E L Morgan, M G Goodman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1992
Identification and characterization of the effector region within human C5a responsible for stimulation of IL-6 synthesisE L Morgan, S Sanderson, W Scholz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1997
Anti-human kappa opioid receptor antibodies: characterization of site-directed neutralizing antibodies specific for a peptide kappa R(33-52) derived from the predicted amino terminal region of the human kappa receptorR R Buchner, S M Vogen, W Fischer, et al.
Cellular Immunology|December 1, 1984
Potentiation of the rat delayed-type hypersensitivity reaction by the Fc portion of human IgG1D N Ernst, J D Kennedy, M V Hobbs, et al.
The Journal of Experimental Medicine|March 1, 1983
Synthetic Fc peptide-mediated regulation of the immune response. I. Characterization of the immunomodulating properties of a synthetic 23-amino acid peptide derived from the sequence of the CH3 domain of human IgG1E L Morgan, J E Shields, C S Campbell, et al.
The American Journal of Sports Medicine|September 1, 1987
Trabecular bone density and menstrual function in women runnersS D Cook, A F Harding, K A Thomas, et al.
Clinical Immunology and Immunopathology|November 1, 1990
C5a-mediated release of interleukin 6 by human monocytesW Scholz, M R McClurg, G J Cardenas, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1990
Induction of human B cell differentiation by Fc region activators. II. Stimulation of IL-6 productionE L Morgan, M V Hobbs, M L Thoman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1993
Anti-C5a receptor antibodies. Characterization of neutralizing antibodies specific for a peptide, C5aR-(9-29), derived from the predicted amino-terminal sequence of the human C5a receptorE L Morgan, J A Ember, S D Sanderson, et al.
Journal of Pediatric Orthopedics|July 1, 1987
Association of bone mineral density and pediatric fracturesS D Cook, A F Harding, E L Morgan, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Federation Proceedings|December 1, 1982
Modulation of the immune response by anaphylatoxin in the microenvironment of the interacting cellsW O Weigle, E L Morgan, M G Goodman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1992
Identification and characterization of the effector region within human C5a responsible for stimulation of IL-6 synthesisE L Morgan, S Sanderson, W Scholz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1997
Anti-human kappa opioid receptor antibodies: characterization of site-directed neutralizing antibodies specific for a peptide kappa R(33-52) derived from the predicted amino terminal region of the human kappa receptorR R Buchner, S M Vogen, W Fischer, et al.
Cellular Immunology|December 1, 1984
Potentiation of the rat delayed-type hypersensitivity reaction by the Fc portion of human IgG1D N Ernst, J D Kennedy, M V Hobbs, et al.
The Journal of Experimental Medicine|March 1, 1983
Synthetic Fc peptide-mediated regulation of the immune response. I. Characterization of the immunomodulating properties of a synthetic 23-amino acid peptide derived from the sequence of the CH3 domain of human IgG1E L Morgan, J E Shields, C S Campbell, et al.
The American Journal of Sports Medicine|September 1, 1987
Trabecular bone density and menstrual function in women runnersS D Cook, A F Harding, K A Thomas, et al.
Clinical Immunology and Immunopathology|November 1, 1990
C5a-mediated release of interleukin 6 by human monocytesW Scholz, M R McClurg, G J Cardenas, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1990
Induction of human B cell differentiation by Fc region activators. II. Stimulation of IL-6 productionE L Morgan, M V Hobbs, M L Thoman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1993
Anti-C5a receptor antibodies. Characterization of neutralizing antibodies specific for a peptide, C5aR-(9-29), derived from the predicted amino-terminal sequence of the human C5a receptorE L Morgan, J A Ember, S D Sanderson, et al.
Journal of Pediatric Orthopedics|July 1, 1987
Association of bone mineral density and pediatric fracturesS D Cook, A F Harding, E L Morgan, et al.
Pageof 9